Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

News

  • Home
  •  
  • News



  • Most Read
  • Latest Comments
  • Blazing clinical trials prove successful to launch new cannabis product
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blazing clinical trials prove successful to launch new cannabis product
    • News

    Smart pain assessment app now used by more than half of Australia’s residential aged care providers
    Public
  • Blazing clinical trials prove successful to launch new cannabis product
    • News

    Fledgling fintech hopes millennials put their Douugh into micro-investing ‘super’ app
    Public
  • Blazing clinical trials prove successful to launch new cannabis product
    • News

    🎵 The knee bone’s connected to the… collagen rope device (?!)
    Public
  • Blazing clinical trials prove successful to launch new cannabis product
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial
    • Review
    • September 1, 2022

Latest Articles

  • ECS Botanics secures distribution rights to bring Terphogz’s ‘The Original Z’ cannabis strain to Australia
    ECS Botanics secures distribution rights to bring Terphogz’s ‘The Original Z’ cannabis strain to Australia
    • News

  • Bioxyne leads the way as Australia’s first manufacturer of pharmaceutical cannabis gummies
    Bioxyne leads the way as Australia’s first manufacturer of pharmaceutical cannabis gummies
    • News

  • Melodiol moves to clear debt with $12m asset fire sale
    Melodiol moves to clear debt with $12m asset fire sale
    • News

  • Althea to make a splash in the US with new cannabis-based sodas
    Althea to make a splash in the US with new cannabis-based sodas
    • News

  • Melodiol Global Health reports revenue growth amid wider acceptance of medicinal cannabis products
    Melodiol Global Health reports revenue growth amid wider acceptance of medicinal cannabis products
    • News

  • MGM Wireless wins Government tender to eliminate truancy
    • News

    MGM Wireless wins Government tender to eliminate truancy

    Australian tech company MGM Wireless (ASX: MWR) has won a major contract from the Western Australia Department of Education to supply student absence notifications to all WA Government schools.  The 2-year contract is valued at approximately $1.3 million with the WA Government having an option to extend a further 2 years. Under terms of the

    Read More
    Public
  • Healthia revenues surge 50% as Australians flock to allied health services
    • News

    Healthia revenues surge 50% as Australians flock to allied health services

    Allied healthcare services provider Healthia (ASX: HLA) has seen a significant growth for the first half of FY20, reporting a 50.2% rise in revenues which has also led the company to declare their maiden dividend.  Compared to the corresponding H1 results for the year prior, Healthia reporting the significant jump to $44.2 million in revenue

    Read More
    Public
  • Oventus secure national distributor in the United States for sleep apnoea treatment
    • News

    Oventus secure national distributor in the United States for sleep apnoea treatment

    Australian medtech company Oventus (ASX: OVN) is surging ahead with its plans to expand into the United States, having reached an agreement with healthcare provider Aeroflow Healthcare for Oventus’ Sleep Treatment Platform and consumables.  The partnership will see Aeroflow offer Oventus products under subcontracts which will initially be introduced in the Southeastern States before being

    Read More
    Public
  • iSignThis-ASX Federal Court conflict heats up with $4.2m investment in ASX rival
    • News

    iSignThis-ASX Federal Court conflict heats up with $4.2m investment in ASX rival

    Despite having been suspended from trade on the ASX (ASX: ASX) by the market operator, fintech company iSignThis (ASX: ISX) is making waves with a strategic $4.2 million investment in the National Stock Exchange (ASX: NSX), a rival market operator to the ASX that domiciles a smaller number of listed companies.  The investment gives iSignThis

    Read More
    Public
  • Coronavirus driving dairy product sales and production, says Jatenergy
    • News

    Coronavirus driving dairy product sales and production, says Jatenergy

    Australia-China trade specialist and consumer good manufacturer Jatenergy (ASX: JAT) has reported a significant uplift in their dairy product brands with the company correlating the rise with the coronavirus breakout.  Whilst the Company did not go into any details regarding the correlation, their Neurio lactoferrin brand of milk products have seen a spike in orders

    Read More
    Public
  • Rebel Group, Houthis, seize $1.68m cash from Petsec Energy bank account
    • News

    Rebel Group, Houthis, seize $1.68m cash from Petsec Energy bank account

    Political risk is often a key consideration for investing in Africa and the Middle East but shareholders of Petsec Energy (ASX: PSA) will be concerned from news that the company has had US $1.68m siphoned out of their bank account and learning that the Houthi rebel group in Yemen are likely to have been involved. 

    Read More
    Public
  • Food Revolution pivots into hand sanitiser production, shares surge 49%
    • News

    Food Revolution pivots into hand sanitiser production, shares surge 49%

    With a bottling production plant already in operation, food processing company Food Revolution Group (ASX: FOD) has received enough interest in hand sanitiser to quickly commission a new bottling line to fill a global supply gap in the sanitary product.  Whilst the company does not have a line of sanitary products, its Melbourne plant has

    Read More
    Public
  • Data breach caps off horrendous few months for Asian matchmaker Love Group
    • News

    Data breach caps off horrendous few months for Asian matchmaker Love Group

    In an age when dating apps are free to download and users swipe-right uninhibited, it is a credit to Hong-Kong based matchmaker Love Group (ASX: LVE) to have still billed out $1.7m in customer receipts for H1 of FY20.  Despite the billings, Love Group has reported a cash operating loss of $228k with political protests

    Read More
    Public
  • Up 110% in 12 months, Johns Lyng continues acquisition spree, adding Air Control Australia
    • News

    Up 110% in 12 months, Johns Lyng continues acquisition spree, adding Air Control Australia

    Construction and building services company Johns Lyng Group (ASX: JLG) has continued its excellent run of form over the past 12 months, today announcing the acquisition of the majority stake in complementary service provider Air Control Australia.  The acquisition of 60% in Air Control Australia for $1.6 million cash and $300,000 of JLG equity will

    Read More
    Public
  • New Medibio MD kicks off 2020 with FDA Approval Roadmap
    • News

    New Medibio MD kicks off 2020 with FDA Approval Roadmap

    With mental health issues continuing to make headlines as greater importance is placed on its value towards wellbeing, medtech company Medibio (ASX: MEB) is developing a Software Medical Device for early detection of depressive symptoms.  Sleep disorders, their onset, and progression, will be the key depressive symptom being targeted by Medibio’s technology which will be

    Read More
    Public
  • «
  • ‹
  • 298
  • 299
  • 300
  • 301
  • 302
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.